Skip to search formSkip to main contentSkip to account menu

OPN-305

Known as: Anti-TLR2 Monoclonal Antibody OPN-305 
A humanized immunoglobulin (Ig) G4 monoclonal antibody directed against toll-like receptor type 2 (TLR2), with potential anti-inflammatory and… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The secreted hexameric form of the dengue virus non-structural protein 1 (NS1) has recently been shown to elicit inflammatory… 
2017
2017
Background The Toll-like receptor plays an essential role in controlling immunity and inflammation. This study was to investigate… 
2016
2016
INTRODUCTION: Alterations of innate immune signaling, including overexpression of TLR2, are common in MDS. Signaling mediated by… 
2016
2016
Toll-like receptors (TLRs) are evolutionary conserved cell surface receptors of the innate immune system. Smoking has significant… 
2015
2015
Toll‐like receptor (TLR) 1, 2, 6 and 10, the TLR2 subfamily, are known to be associated with immunity against tuberculosis. We… 
2014
2014
Background Toll-like receptors (TLRs) are important molecules for both innate and adaptive immune responses. The prevalence of… 
2013
2013
Toll-like receptors (TLRs) are important mediators of inflammatory responses by recognition of many pathogen-related molecules… 
2013
2013
OPN-305 is a humanized IgG4 monoclonal antibody against Tolllike receptor (TLR)2 being developed by Opsona Therapeutics. It is… 
2009
2009
Chlamydia pneumoniae is an obligate intracellular gram‐negative bacterium, which causes respiratory infections in humans. It can…